Search by Drug Name or NDC

    NDC 16714-0767-02 Cefixime 200 mg/5mL Details

    Cefixime 200 mg/5mL

    Cefixime is a ORAL POWDER, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by NorthStar RxLLC. The primary component is CEFIXIME.

    Product Information

    NDC 16714-0767
    Product ID 16714-767_f15f86c9-5ebe-800a-e053-2995a90af842
    Associated GPIs 02300060001920
    GCN Sequence Number 044428
    GCN Sequence Number Description cefixime SUSP RECON 200 MG/5ML ORAL
    HIC3 W1Y
    HIC3 Description CEPHALOSPORIN ANTIBIOTICS - 3RD GENERATION
    GCN 92368
    HICL Sequence Number 003999
    HICL Sequence Number Description CEFIXIME
    Brand/Generic Generic
    Proprietary Name Cefixime
    Proprietary Name Suffix n/a
    Non-Proprietary Name cefixime
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form POWDER, FOR SUSPENSION
    Route ORAL
    Active Ingredient Strength 200
    Active Ingredient Units mg/5mL
    Substance Name CEFIXIME
    Labeler Name NorthStar RxLLC
    Pharmaceutical Class Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206938
    Listing Certified Through 2024-12-31

    Package

    NDC 16714-0767-02 (16714076702)

    NDC Package Code 16714-767-02
    Billing NDC 16714076702
    Package 75 mL in 1 BOTTLE (16714-767-02)
    Marketing Start Date 2018-05-11
    NDC Exclude Flag N
    Pricing Information N/A